October 25, 2023 11:02 AM EDT

BioXcel says independent audit of Alzheimer’s study found misconduct did not impact data reliability

BioXcel Therapeutics said Wednesday that it still plans to use data from a site in its Phase III Alzheimer’s disease study …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

BioX­cel says in­de­pen­dent au­dit of Alzheimer’s study found mis­con­duct did not im­pact da­ta re­li­a­bil­i­ty